Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Current Taxes (2024 - 2025)

Historic Current Taxes for Axsome Therapeutics (AXSM) over the last 2 years, with Q1 2025 value amounting to $960000.0.

  • Axsome Therapeutics' Current Taxes rose 9512.2% to $960000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $960000.0, marking a year-over-year increase of 9512.2%. This contributed to the annual value of $960000.0 for FY2024, which is N/A changed from last year.
  • Per Axsome Therapeutics' latest filing, its Current Taxes stood at $960000.0 for Q1 2025, which was up 9512.2% from $960000.0 recorded in Q4 2024.
  • In the past 5 years, Axsome Therapeutics' Current Taxes ranged from a high of $960000.0 in Q4 2024 and a low of $492000.0 during Q1 2024